Literature DB >> 3021048

In vitro activity of ketoconazole against herpes simplex virus.

J C Pottage, H A Kessler, J M Goodrich, R Chase, C A Benson, K Kapell, S Levin.   

Abstract

The effects of ketoconazole alone and in combination with acyclovir and adenine arabinoside upon the replication of herpes simplex virus types 1 and 2 (HSV-1 and -2) were investigated by using a yield reduction assay. Ketoconazole demonstrated antiviral activity against HSV-1 and -2 and synergistic antiviral activity when it was combined with acyclovir. Combinations of ketoconazole with adenine arabinoside resulted in either interference or indifference. The effects of ketoconazole upon the protein synthesis of HSV-2-infected cells were also determined in an effort to define the mechanism of action for the antiviral activity of ketoconazole. There was no reduction of HSV proteins when compared with acyclovir. These findings suggest that further investigations of the use of ketoconazole for the treatment of HSV infections are warranted.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3021048      PMCID: PMC180521          DOI: 10.1128/AAC.30.2.215

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  Antiviral effects of amphotericin B methyl ester.

Authors:  G W Jordan; E C Seet
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Effect of combinations of acyclovir with vidarabine or its 5'-monophosphate on herpes simplex viruses in cell culture and in mice.

Authors:  R F Schinazi; J Peters; C C Williams; D Chance; A J Nahmias
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

4.  Imidazole and polyene activity against chloroquine-resistant Plasmodium falciparum.

Authors:  M A Pfaller; D J Krogstad
Journal:  J Infect Dis       Date:  1981-10       Impact factor: 5.226

5.  Activity of imidazoles against Leishmania tropica in human macrophage cultures.

Authors:  J D Berman
Journal:  Am J Trop Med Hyg       Date:  1981-05       Impact factor: 2.345

Review 6.  Mechanism of action of antifungal drugs, with special reference to the imidazole derivatives.

Authors:  M Borgers
Journal:  Rev Infect Dis       Date:  1980 Jul-Aug

7.  Combined effect of acyclovir and amphotericin B on the replication of pseudorabies virus in BHK-21 cells.

Authors:  B Malewicz; M Momsen; H M Jenkin
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

8.  Effects of amphotericin B on hepatitis B virus.

Authors:  H A Kessler; J Dixon; C R Howard; K Tsiquaye; A J Zuckerman
Journal:  Antimicrob Agents Chemother       Date:  1981-12       Impact factor: 5.191

9.  Inhibition of in vitro HBsAg production by amphotericin B and ketoconazole.

Authors:  J C Pottage; H A Kessler
Journal:  J Med Virol       Date:  1985-07       Impact factor: 2.327

10.  Effect of acyclovir on viral protein synthesis in cells infected with herpes simplex virus type 1.

Authors:  P A Furman; P V McGuirt
Journal:  Antimicrob Agents Chemother       Date:  1983-02       Impact factor: 5.191

View more
  3 in total

1.  Single-Center Pharmacokinetic Study and Simulation of a Low Meropenem Concentration in Brain-Dead Organ Donors.

Authors:  Jae-Myeong Lee; Joo Won Lee; Tae Seok Jeong; Eun Sook Bang; So Hee Kim
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

2.  Effects of antimicrobial agents on growth and chemotaxis of Trichomonas vaginalis.

Authors:  B Sugarman; N Mummaw
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

Review 3.  Antiviral Activity of Approved Antibacterial, Antifungal, Antiprotozoal and Anthelmintic Drugs: Chances for Drug Repurposing for Antiviral Drug Discovery.

Authors:  Leena Abdulaziz; Esraa Elhadi; Ejlal A Abdallah; Fadlalbaseer A Alnoor; Bashir A Yousef
Journal:  J Exp Pharmacol       Date:  2022-03-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.